BREAKING NEWS

India bans export of key malaria drug amid coronavirus outbreak

By REUTERS

MARCH 25, 2020 05:42

The Indian government said on Wednesday that it is banning the export of hydroxychloroquine and formulations made from the medication, as experts test the efficacy of the drug in helping treat patients infected with COVID-19.

There are currently no approved treatments, or preventive vaccines for COVID-19, the highly contagious, sometimes deadly respiratory illness caused by the new coronavirus. Researchers are studying existing treatments and working on experimental ones, but most current patients receive only supportive care such as breathing assistance.

Hydroxychloroquine, a malaria drug, is among the medications that are being tested, as a potential treatment for patients with the disease. Earlier this week, the American Society of Health-System Pharmacists (ASHP), which maintains a list of drug shortages, said hydroxychloroquine was in shortage.

Houthis launch drone into Israel, crashes in open area near Gaza border

By JERUSALEM POST STAFF

12/25/2024 05:56 PM

Police disperse Tel Aviv hostage families candle lighting ceremony

By JERUSALEM POST STAFF

12/25/2024 05:28 PM

Judges urge speeding up Netanyahu testimony - report

By JERUSALEM POST STAFF

12/25/2024 04:09 PM

Katz says security control over Philadelphi Corridor will stay with IDF

By JERUSALEM POST STAFF

12/25/2024 04:06 PM